BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18426800)

  • 1. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.
    Zemskova M; Sahakian E; Bashkirova S; Lilly M
    J Biol Chem; 2008 Jul; 283(30):20635-44. PubMed ID: 18426800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
    Holder SL; Abdulkadir SA
    Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
    Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
    Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
    Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
    Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
    van der Poel HG; Zevenhoven J; Bergman AM
    Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
    Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.
    Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR
    Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.
    Paulin R; Courboulin A; Meloche J; Mainguy V; Dumas de la Roque E; Saksouk N; Côté J; Provencher S; Sussman MA; Bonnet S
    Circulation; 2011 Mar; 123(11):1205-15. PubMed ID: 21382889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
    Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
    Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.
    Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA
    Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
    Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
    Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.
    Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ
    Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.
    Liu K; Gao H; Wang Q; Wang L; Zhang B; Han Z; Chen X; Han M; Gao M
    Cancer Sci; 2018 May; 109(5):1369-1381. PubMed ID: 29575334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.
    Szydłowski M; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Derezińska E; Hoser G; Wasilewska D; Szymańska-Giemza O; Jabłońska E; Białopiotrowicz E; Sewastianik T; Polak A; Czardybon W; Gałęzowski M; Windak R; Zaucha JM; Warzocha K; Brzózka K; Juszczyński P
    Blood; 2017 Sep; 130(12):1418-1429. PubMed ID: 28698206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of quinones as novel PIM1 kinase inhibitors.
    Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
    Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
    Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.